stock
MGX · Metagenomi Therapeutics, Inc.
What Metagenomi Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live MGX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on MGX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 37,777,105 as of 2026-08-06 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -83.0%
- ROA
- -53.8%
Health
- Current ratio
- 4.5x
- Debt/equity
- —
Deep value
- NCAV
- $63.33M
- NCAV per share
- $1.68
- Price/NCAV
- Locked
- NNWC
- -$22.11M
- NNWC per share
- -$0.59
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$28.77M | -$27.48M | 10-Q filed 2026-08-10 |
| 2026-03-31 | $1.25M | —Gross profit: unreported by this company. | -$24.59M | -$23.06M | 10-Q filed 2026-08-10 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $3.91M | —Gross profit: unreported by this company. | -$24.37M | -$22.53M | 10-K filed 2026-03-05 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $8.66M | —Gross profit: unreported by this company. | -$22.84M | -$20.39M | 10-Q filed 2025-11-12 |
| 2025-06-30 | $8.51M | —Gross profit: unreported by this company. | -$20.99M | -$19.91M | 10-Q filed 2026-08-10 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-03-31 | $4.13M | —Gross profit: unreported by this company. | -$27.82M | -$25.04M | 10-Q filed 2026-08-10 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $9.61M | —Gross profit: unreported by this company. | -$20.62M | -$23.40M | 10-K filed 2026-03-05 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $11.51M | —Gross profit: unreported by this company. | -$22.38M | -$18.77M | 10-Q filed 2025-11-12 |
- Assets
- $173.70M
- Equity
- $112.57M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $25.21M | -$96.01M | -$87.87M | -$89.47M |
| 2024-12-31 | $52.30M | -$88.90M | -$78.06M | -$112.19M |
| 2023-12-31 | $44.76M | -$78.49M | -$68.25M | -$101.22M |
Company filings
events
Regulation FD disclosure
Regulation FD disclosureSep 218-KResults
ResultsAug 108-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 98-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureMay 118-KResults
ResultsMar 58-KBylaws or fiscal year change, Regulation FD disclosure
Bylaws or fiscal year changeRegulation FD disclosureJan 128-K
5% owners ()
Thomas Brian C.
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Reid Laurence
Director
Buy$23,401Sep 11, 7:51 PM ET
Wein Matthew
See Remarks
Sale$415Sep 10, 3:47 PM ET
Irish Jian
See Remarks, Director
Sale$2,479Sep 10, 3:40 PM ET
Wapnick Pamela
Chief Financial Officer
Sale$2,214Sep 10, 3:34 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named MGX, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about MGX.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on MGX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the MGX board